Vyome Holdings, Inc. (HIND)
NASDAQ: HIND · Real-Time Price · USD
1.710
-0.080 (-4.47%)
Oct 26, 2026, 4:00 PM EDT - Market closed
Vyome Holdings Revenue
Vyome Holdings had revenue of $26.96K in the quarter ending June 30, 2026, a decrease of -46.04%. This brings the company's total for the last twelve months to $129.73K, down -67.12% year-over-year. In the year 2025, Vyome Holdings had annual revenue of $319.71K with 24.43% growth. That makes Vyome Holdings the 45,859th largest company in the world by revenue and 6,733rd in the United States.
Revenue (ttm)
$129.73K
Revenue Growth
-67.12%
P/S Ratio
92.52
Revenue / Employee
$9,266
Employees
14
Market Cap
12.00M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 319.71K | 62.77K | 24.43% |
| Dec 31, 2024 | 256.94K | -159.00K | -38.23% |
| Dec 31, 2023 | 415.94K | 33.08K | 8.64% |
| Dec 31, 2022 | 382.87K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
HIND News
- 16 hours ago - Vyome Co-Founder Dr. Shiladitya Sengupta Promoted to Professor at Harvard Medical School - Business Wire
- 6 days ago - Vyome Holdings Transcript: Chardan's 10th Annual Healthcare Conference - Transcripts
- 21 days ago - Vyome receives USPTO Notice of Allowance for U.S. patent covering VT-1908 - TheFly
- 21 days ago - Vyome Receives USPTO Notice of Allowance for U.S. Patent Covering VT-1908, its Novel Topical Mycophenolate Program Targeting the $20+ Billion Ocular Inflammation Market - Business Wire
- 6 weeks ago - Vyome appoints Leonard as Chief Financial Officer - TheFly
- 6 weeks ago - Vyome Appoints Experienced Public Company Finance Executive Jerry Leonard as Chief Financial Officer - Business Wire
- 7 weeks ago - Vyome initiated with a Buy at Chardan - TheFly
- 1 month ago - Vyome names Jerry Leonard as CFO - TheFly